Adenosine A1 and A2A receptors are uniquely positioned to counteract the excessive stimulation of dopamine receptors produced by drugs of abuse. Thus, adenosine receptor stimulation provides a “brake” ...

In a recent study by Paolo Barone and colleagues, a dopamine agonist, pramipexole ... indicated that the overall effect was 80% direct drug influence on depressive symptoms, attributable to ...

For further clarification, consult your healthcare provider. This medication is a non-selective dopamine agonist, prescribed for acute, intermittent treatment of hypomobility and loss of control ...

The mechanism of the drug's beneficial effect on cardiovascular disease remains to be determined. Recently, timed-release bromocriptine (Cycloset), a sympatholytic dopamine D 2 receptor agonist ...

Dopamine agonists are the first-line treatment for RLS; their efficacy has mainly been demonstrated by short-term trials of oral medications. Oertel and colleagues (2011) aimed to determine the ...

For further clarification, consult your healthcare provider. This medication is a dopamine agonist, prescribed for Parkinson's disease and restless leg syndrome (RLS). It works by acting in place ...